Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FranceBack to France

Clinical trials in Ajaccio

4 clinical trials in Ajaccio, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Ajaccio at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Ajaccio

Open in trial search

Secondary progressive multiple sclerosis

Recruiting

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Relapsing-remitting multiple sclerosis

Recruiting

Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dimethyl Fumarate
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Staphylococcal infection

Recruiting

Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate
  • Sponsor:Assistance Publique Hopitaux De Paris

Renal cell carcinoma

Recruiting

Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Institut Gustave Roussy

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Ajaccio

What the registry says about research in the country

01 Neurology Research

Innovative research focusing on Multiple Sclerosis treatment optimization, comparing maintenance versus de-escalation strategies in anti-CD20 therapy for patients with relapsing-remitting forms.

  • Disease Activity Monitoring
  • Treatment Optimization
  • Platform Therapy Evaluation

This research aims to advance personalized treatment approaches for MS patients through careful evaluation of therapeutic strategies.

02 Infectious Disease Research

Groundbreaking studies in treating catheter-related bloodstream infections, specifically targeting infections caused by Staphylococcus aureus through innovative single-dose treatments.

  • Antibiotic Therapy Optimization
  • Infection Management
  • Treatment Duration Assessment

The research explores simplified treatment approaches comparing single-dose interventions with standard antibiotic protocols.

Back to FranceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.